June 27 ICOC/ARS Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH, TREATMENTS, AND CURES INITIATIVE OF 2020

Date: June 27, 2024
Time: 9:00 am to 4:00 pm*
Main Location: Hyatt Regency San Francisco Airport, Sequoia A
1333 Old Bayshore Hwy
Burlingame, CA 94010

 

Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below.

 

Public Comment Instructions

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: 

  • Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment.
  • Once we call your name you may have up to 3 Minutes (depending on the number of members of the public wishing to speak) to make your public comment; please remember to be respectful of the time limit.
  • Written comment may be sent to the following email address: cmandac@cirm.ca.gov
  • Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location with the same limitations as those imposed on any other member of the public.

 

YouTube:
https://www.youtube.com/cirmtv

Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 893 7836 6818
Passcode: 240627

 

Open Session

  1. Call to Order
  2. Roll Call
  3. Chair’s Report
  4. Interim President’s Report

 Consent Calendar

  1. Consideration of Minutes from March 28 ICOC/ARS Meeting, April 25 ARS Meeting, and May 30 ARS Meeting
  2. Consideration of Appointment of Scientific Members to the Grants Working Group
  3. Consideration of Appointment of a Member to the Accessibility & Affordability Working Group
  4. Approval of Requests to Attend Remotely (Gov’t Code Section 11123.2(j))

Open Session

  1. Consideration of Appointment of Chair to the Task Force on Neuroscience and Medicine
  2. Consideration of Applications Submitted in Response to Clinical Trial Stage Projects Program Announcements (CLIN 1 or 2)
  3. Consideration of CIRM Interim Research Budget for FY ‘24-’25
  4. Consideration of CIRM Administrative Budget for FY ‘24-‘25
  5. Consideration of Clinical Program Application Processing and Revisions to Grants Working Group Bylaws and CLIN1/2 Concept Plans
  6. Consideration of Recommendations from Governance Subcommittee Regarding Compensation Policy and Relocation Policy

Closed Session

  1. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda item 10 (Health & Safety Code 125290.30(f) (3) (B) and (C)).
  2. Discussion of Personnel [Evaluation of ICOC Chair and ICOC Vice-Chair] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(f) (3) (D))

Open Session

  1. Update from Presidential Search Subcommittee
  2. Update on Strategic Allocation Framework
  3. Update on Communications
  4. General Comments on ARS Process
  5. Public Comment
  6. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Claudette Mandac at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Claudette Mandac at the California Institute for Regenerative Medicine at cmandac@cirm.ca.gov.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov/.

The Committee may take action on any item listed on this agenda.

*The duration of the meeting is an estimate, only. The meeting may continue beyond this estimated time in order to address the items on this agenda.

Date Published: June 17, 2024
Last Modified: October 30, 2024